CAMBRIDGE, Mass. & KOBE CITY, Japan--(BUSINESS WIRE)--Beam Therapeutics and Bio Palette today announced an exclusive cross-license agreement around each companies’ base editing intellectual property.
Exercises Option to Exclusively License Base Editing Technology from Rutgers, The State University of New Jersey Cambridge, UK, 14 January 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a new license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for the technology underlying its Pin-point™ base editing ...
The partnership builds upon Origin Agritech's long-term collaboration with China Agricultural University. Together, they identified two key regulatory genes controlling corn leaf angle—ZmRAVL1 and ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with ...
BEIJING, Nov. 10, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback